Open Access

The 2011 Medical Molecular Hydrogen Symposium: An inaugural symposium of the journal Medical Gas Research

Medical Gas Research20111:10

https://doi.org/10.1186/2045-9912-1-10

Received: 9 March 2011

Accepted: 7 June 2011

Published: 7 June 2011

Abstract

This report summarizes a brief description/history of the Hydrogen Research Meetings as well as key presentations/oral abstracts delivered in the most recent symposium. Additionally, we introduced 38 diseases and physiological states for which hydrogen exhibits beneficial effects.

Introduction

Novel medical gases are expected to provide us with more effective therapeutic interventions and preventive medicine. In the past decades, there has been extraordinary, rapid growth in our knowledge of gaseous molecules, including nitric oxide, carbon monoxide, and hydrogen sulfide, which have been known to play important roles in biological systems. Additionally, since Dr. Shigeo Ohta's group's pioneering paper was published in the June 2007 Nature Medicine showing the potency of hydrogen as a therapeutic gas for oxidative stress-mediated diseases including cerebral infarction [1], basic and clinical hydrogen research has resurfaced. In Japan, the birthplace of hydrogen gas research, Dr. Ohta (Nippon Medical School), who is currently serving as an Associate Editor of Medical Gas Research, organized annual "Medical Molecular Hydrogen Research Meetings" in 2009 and 2010 to provide investigators with focused opportunities to share their rapid scientific progress. Most recently, we organized the Medical Molecular Hydrogen Symposium on February 18-19, 2011 at the Nagoya University Hall (Figure 1). The latest meeting is a "kick-off" inaugural meeting for the newly launched journal Medical Gas Research (MGR), which aims to promote the exchange and dissemination of the latest scientific findings.
Figure 1

A snap shot of the Medical Molecular Hydrogen Symposium in 2011.

This report summarizes a brief description/history of the Hydrogen Research Meetings as well as key presentations/oral abstracts delivered in the most recent symposium.

First Medical Molecular Hydrogen Research Meeting, 2009

The first scientific meeting organized by Dr. Ohta was held on February 7, 2009 in Tokyo. 42 scientists and clinicians from 30 individual institutes were invited. The aim of the meeting was to unite innovative investigators to discuss and propagate medical hydrogen research. Dr. Ohta delivered the keynote presentation, in which he gave a brief history of hydrogen medicine and emphasized the huge impact of his report published in Nature Medicine. He pointed out the great interest in the field, expressed in more than 30 personal communications with investigators, and the resulting need to widen the scope of basic/clinical research to the whole world. He mentioned the successful application of hydrogen gas in a rat neonatal hypoxic brain injury model in collaboration with Dr. Xuejun Sun (Second Military Medical School, Shanghai, China) [2], who is currently serving as an Associate Editor. Dr. Atsunori Nakao (Department of Surgery, University of Pittsburgh), who is also an Associate Editor, presented the promising preliminary results of a collaborative study with Dr. Ohta's group in which hydrogen water was applied in a rat kidney transplant model. Dr. Nakao's report clearly showed survival benefits for transplant recipients. He received a research award at this meeting and his report was later published in Kidney International [3, 4]. Dr. Takahisa Kawai (Forsythe Research Institute, Boston, MA, USA), who is an editorial board member, focused on hydrogen generated by intestinal bacteria. His initial studies elegantly demonstrated the critical physiological roles of gut microflora-derived hydrogen [5]. There was a general consensus that both clinicians and researchers in the field of molecular hydrogen research should gather and exchange accumulating knowledge in future annual meetings.

Second Medical Molecular Hydrogen Research Meeting, 2010

The second meeting was also organized by Dr. Ohta on February 3, 2010 in Tokyo. 47 basic scientists and clinical physicians, as well as 23 corporate participants were invited and shared the latest developments in medical issues related to hydrogen. This meeting hosted a keynote lecture, an invited lecture, two special lectures, and twelve platform presentations. After Dr. Ohta began his keynote lecture by remarking on the impressive progress over the last year, Dr. Sun gave an invited lecture and introduced the great effects of intraperitoneal administration of saline dissolved with H2 in several model animals. Dr. Takashi Asada (Department of Psychiatry, Tsukuba University), an authority on Alzheimer disease, presented the results of clinical studies involving patients with mild cognitive impairment (MCI). He started clinical intervention studies on MCI patients by orally administering hydrogen water; the project is still in progress. Dr. Toru Yoshikawa (Kaohsiung Medical University, Taiwan) also gave a special lecture on the physical aspects of hydrogen effects. He presented the physical characteristics of molecular hydrogen's interaction with water in biological systems.

Third Medical Molecular Hydrogen Research Meeting, 2011

The third meeting was organized by Dr. Kenji Ohno (Nagoya University Graduate School of Medicine), an editorial board member, and held in Nagoya on Feb 18-19, 2011. This symposium mainly focused on molecular hydrogen and covered a wide-range of therapeutic gases, including hydrogen sulfide (H2S), nitric oxide (NO), and carbon monoxide (CO). A total of 98 academic and 53 corporate registrants attended the meeting from Japan (144), USA (5), Korea (1), and Taiwan (1). The meeting's timetable, titles, and speakers are summarized in Table 1. We also introduced 38 diseases and physiological states for which hydrogen exhibits beneficial effects (Table 2).
Table 1

Scientific Program of the Medical Molecular Hydrogen Symposium in 2011

Feb. 18, 2011

Title

Speaker

13:00

Opening Remarks

Kinji Ohno, Nagoya Univ.

13:05

Keynote Lecture "Recent progress towards hydrogen medicine"

Shigeo Ohta, Nippon Medical Sch.

13:35

Scientific Session I

 
 

1. Effects of hydrogen-rich water on kidney functions in SHR.Cg-Lepr cp /NDmcr rat - a metabolic syndrome model rat

Michio Hashimoto, Shimane Univ.

 

2. Hydrogen-rich UW solution attenuates renal cold ischemia reperfusion injury

Toyofumi Abe, Osaka Univ.

 

3. Therapeutic effect of maternal hydrogen water administration in a rat model of fetal brain damage

Yukio Mano, Nagoya Univ.

 

4. Effects of hydrogen water on human skin and hair

Yoshiaki Kurita, Hosei Univ.

14:23

Coffee Break

 

14:50

Scientific Session II

 
 

5. Consumption of hydrogen water prevents memory impairment accompanying neurodegeneration in transgenic mice

Ikuroh Ohsawa, Metropolitan Instittue of Gerontology

 

6. Appearance of hydrogen gas in the human skin after the ingestion of hydrogen-rich water and inhalation of hydrogen gas

Kazutoshi Nose, National Cerebral and Cardiovascular Center

 

7. Effectiveness of long-term intake of hydrogen rich water in a patient with MELAS

Mikio Hirayama, Kasugai Municipal Hospital

 

8. Effectiveness of hydrogen rich water on myopathy

Tohru Ibi, Aichi Medical Univ.

 

9. Inhaled hydrogen gas therapy for prevention of lung transplant-induced ischemia/reperfusion injury in rats

Tomohiro Kawamura, Univ. of Pittsburgh

15:50

Invited Lecture I "Deadly gas can save a life! -Preclinical studies using carbon monoxide/hydrogen-"

Atsunori Nakao, Univ. of Pittsburgh

16:30

Break

 

16:40

Invited Lecture II "Medical Gas Research"

John Zhang, Loma Linda Univ.

17:20

Invited Lecture III "A hypothesis on biological protection from space radiation through the use of therapeutic gases"

Michael P. Schoenfeld, NASA Marshall Space Flight Center

18:10

Banquet

 

Feb. 19, 2011

  

9:30

Symposium I "CO as a therapeutic modality"

Organizer: Atsunori Nakao, Univ. of Pittsburgh

 

S1-1. Is exhaled carbon monoxide a marker of oxidative stress?

Tohru Takahashi, Okayama Prefecture Univ.

 

S1-2. A tracer analysis study demonstrates redistribution of endogenous carbon monoxide from blood to tissue in human body

Makoto Sawano, Saitama Medical Univ.

 

S1-3. Translational research of carbon monoxide therapy using miniature swine

Hisashi Sahara, Kagoshima Univ.

10:30

Special Lecture "Function of hydrogen sulfide and its therapeutic applications"

Hideo Kimura, National Center of Neurology and Psychiatry

11:10

Break

 

11:20

Scientific Session III

 
 

10. Hydrogen from intestinal bacteria is protective for Con A-induced Hepatitis

Mikihito Kajiya, The Forsyth Institute

 

11. Abnormal breath hydrogen production by ingestion of lactulose in Parkinson's disease

Masaaki Hirayama, Nagoya Univ.

 

12. A new portable breath hydrogen analyzer and its clinical application

Akito Shimouchi, National Cerebral and Cardiovascular Center

 

13. Application of hydrogen water in the dental field

Noriyuki Tanaka, Uchida Dental Clinic

12:08

Lunch

 

12:45

Symposium II "Biological Effects of NO"

Hirosuke Kobayashi, Kitasato Univ.

 

S2-1. NO-ROS cellular signaling mediated via nitrated cyclic nucleotide

Hideshi Ihara, Osaka Prefecture Univ.

 

S2-2. Relationship between protein S-nitrosylation and neuronal death

Takashi Uehara, Wakayama Mediccal Univ.

 

S2-3. Role of nitrosative stress in chronic obstructive pulmonary disease

Ryujiro Sugimoto, Iwakuni Clinical Center

 

S2-4. Effects of simultaneous inhalation of nitric oxide and hydrogen on mouse myocardial ischemia-reperfusion injury

Hirosuke Kobayashi, Kitasato Univ.

14:15

Scientific Session 4

 
 

14. Effect of hydrogen rich water against a progression of disease and a formation of liver tumor in NASH model mouse

Daisuke Kawai, Okayama Univ.

 

15. The dynamic movement of H2 in a liver and its effects

Naomi Kamimura, Nippon Medical Univ.

 

16. Molecular hydrogen effectively protects cereulide-induced liver injury by suppressing apoptosis

Sayaka Sobue, Chubu Univ.

14:51

Closing Remarks

Kinji Ohno, Nagoya Univ.

Table 2

Thirty-eight diseases and physiological states for which hydrogen effects are reported

Disease/Physiology

Species

Source of H2

Reference

Brain

   

Cerebral infarction

rodent

gas

[1]

Superoxide in brain

rodent

water

[6]

Neonatal brain hypoxia

rodent

gas

[2, 7]

 

rodent

saline

[8]

 

pig

gas

[9]

Restraint-induced dementia

rodent

water

[10]

Alzheimer's disease

rodent

saline

[11]

Senile dementia

rodent

water

[12]

Parkinson's disease

rodent

water

[13, 14]

Hemorrhagic cerebral infarction

rodent

gas

[15]

Traumatic brain injury

rodent

gas

[16]

Spinal cord

   

Spinal cord injury

rodent

saline

[17]

Eye

   

Glaucoma

rodent

eye drop

[18]

Corneal alkali-burn

rodent

eye drop

[19]

Ear

   

Hearing disturbance

rodent

medium

[20]

 

rodent

gas

[21]

 

rodent

water

[22]

Lung

   

Lung cancer

Cells

medium

[23]

Oxygen-induced lung injury

rodent

saline

[24, 25]

Lung transplantation

rodent

gas

[26]

Heart

   

Myocardial infarction

rodent

gas

[27]

 

rodent

saline

[28]

Heart transplantation

rodent

gas

[29]

Irradiation-induced heart injury

rodent

water

[30]

Liver

   

Hepatic ischemia

rodent

gas

[31]

Hepatitis

rodent

bacteria

[5]

Obstructive jaundice

rodent

saline

[32]

Kidney

   

Cisplatin nephropathy

rodent

gas, water

[33]

 

rodent

water

[34]

Hemodialysis

human

dialysis

[35, 36]

Kidney transplantation

rodent

water

[4]

Pancreas

   

Acute pancreatitis

rodent

saline

[37]

Intestine

   

Intestinal graft

rodent

gas

[3]

 

rodent

saline

[38, 39]

Ulcerative colitis

rodent

gas

[40]

Blood vessel

   

Atherosclerosis

rodent

water

[41]

Metabolism

   

Diabetes mellitus type 2

human

water

[42]

Metabolic syndrome

human

water

[43]

Obesity/Diabetes

rodent

water

[44]

Cancer

   

Tongue carcinoma

cells

medium

[45]

Inflammation and allergy

   

Allergy type I

rodent

water

[46]

Sepsis

rodent

gas

[47]

Zymosan-induced inflammation

rodent

gas

[47]

Others

   

Multipotent stromal cells

cells

gas

[48]

Radiation injury

cells

medium

[49, 50]

Although the observations are not directly relevant to diseases, Turmeric [51] and acarbose [52] increase hydrogen production by intestinal bacteria in humans.

Hydrogen

Dr. Ohta gave a keynote lecture and introduced a number of hydrogen's potent efficacies on a broad spectrum of diseases in animal and human models, as well as the emerging molecular bases of hydrogen's effects. He emphasized the following points: (i) In the three and a half years since the first hydrogen paper was published in Nature Medicine, more than 70 original papers have been published in leading biological/medical journals. Based on cumulative knowledge, beneficial biological effects of hydrogen have been established with no doubt. (ii) There are several ways to intake or consume hydrogen, including inhaling hydrogen gas, drinking water dissolved with hydrogen (hydrogen water), taking a hydrogen bath, injecting hydrogen saline, dropping hydrogen saline into the eye, and increasing production of intestinal hydrogen by bacteria. (iii) Hydrogen shows not only anti-oxidative stress effects, but also has various anti-inflammatory and anti-allergic effects. (iv) The primary molecular target of hydrogen remains unknown. In their first report published in 2007 [1], Dr. Ohta's group indicated that cells cultured in H2-rich medium were protected against oxidative stress by the hydroxyl radical-scavenging activity of H2; however, recent evidence clearly shows that the scavenging property is not the only explanation for the potent beneficial effects of hydrogen. For example, the amount of orally administered H2 may not be enough to scavenge hydroxyl radicals. In addition, it is likely that the dwell time of H2 in the body is too short to scavenge a large amount of hydroxyl radicals that are continuously generated. (v) Several reports demonstrate an effect on the regulation of gene expressions and protein-phosphorylations; however, the transcriptional factors and kinases involved in the functions afforded by H2 have not been identified. It also remains unknown whether the regulations are directly performed by H2. (vi) The amount of administered H2 is independent of the extent of effects. Intestinal bacteria seem to produce more than 1 liter of H2 gas per day, whereas the amount of H2 originating from drinking hydrogen water is less than 50 ml. Nevertheless, additional H2 in drinking hydrogen water is unambiguously effective. Many mysteries of hydrogen therapy remain unsolved. He closed his talk by emphasizing that the molecular mechanisms underlying the amazing effects of a very small amount of H2 remain elusive.

Sixteen platform speakers presented clinical and basic aspects of the medical application of molecular hydrogen. Among them were three treatments for patients with neurological and dental diseases. Dr. Mikio Hirayama (Department of Neurology, Kasugai City Hospital) and his colleagues presented their clinical report of treatment for a patient with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episode (MELAS) syndrome. He reported that a 33-year-old female patient was successfully treated by drinking hydrogen-containing water for one and half years, which reduced the frequency of episodic cerebral ischemia. Dr. Tohru Ibi (Department of Neurology, Aichi Medical School) conducted an open label trial on mitochondrial disorders and inflammatory myopathies, and demonstrated a remarkable reduction of several serum markers specific for myelopathy. He also conducted a double-blind crossover trial; however, the trial showed no significant effects, which was likely due to a small amount of hydrogen water and to a short observation period. Both reports suggest that oral administration of hydrogen water is likely to be effective for mitochondrial diseases. Dr. Noriyuki Tanaka (Uchida Dental Clinic) reported that direct dental application of hydrogen water on injured regions reduced inflammation and promoted healing in dental operations, including tooth extraction.

Medical Gas Research's editor-in-chief Dr. John Zhang (Department of Neurosurgery, Loma Linda University, CA) gave a greeting talk, introducing the aims and scope of the journal. Dr. Zhang pointed out the importance of stimulating medical gas research and collaborating with a wide-range of people in various fields.

Dr. Michael P. Schoenfeld from NASA gave a special lecture on the potential application of H2 to protect astronauts from radiation-mediated injury during long space travel. Cosmic radiation induces serious oxidative stress, which is one of the major issues to be resolved by hydrogen research.

Other Medical Gases (NO, CO, and H2S)

Mammals produce NO, CO, and H2S by their native enzymes; however, mammals lack an enzyme to produce H2. All four gases modulate signaling pathways and have some therapeutic effects. Thus, we invited leading NO, CO, and H2S researchers to the symposium.

Dr. Hideo Kimura (National Center of Neurology and Psychiatry), an editorial board member, gave a special lecture on hydrogen sulfide (H2S). Dr. Kimura discovered biological roles for H2S. He reviewed studies on H2S from past to present and emphasized the potential for actual medical applications.

Dr. Nakao organized a mini-symposium on carbon monoxide (CO). In the mini-symposium, the discrepancy between the animal and human models was discussed. CO binds to human hemoglobin more strongly than to murine hemoglobin; this seems to be the reason why CO is more toxic in clinical studies.

Dr. Hirosuke Kobayashi (Department of Respiratory Medicine, Kitasato University), an editorial board member, organized a mini-symposium on nitric oxide (NO). Dr. Kobayashi explained the contradictory properties of NO; while it is medically beneficial, it is also toxic and enhances oxidative stress. NO has been approved as a therapeutic agent in clinical practice. He presented the amazing effects of inhaling an NO and H2 mixture. NO enhances oxidative stress and induces production of peroxynitrite, and H2 reduces peroxynitrite derived from NO. Indeed, he presented that the mixture of NO and H2 improves the number of surviving myocytes in a rodent model of myocardial infarction. The mixture of NO and H2 may be a promising modality for clinical applications.

In addition to NO, CO, and H2S, Dr. Zhang addressed potential effects of inhaled xeon and helium in animal models in his invited lecture.

Commercial products

Six companies financially supported the meeting by demonstrating their new commercial products. Melodian Co Ltd. presented a sports drink containing H2, and Miz Co Ltd. introduced an interesting device to prepare a clinically applicable H2-rich infusion solution by simply soaking an infusion bag in hydrogen water. With this method, no other treatment is necessary to prepare hydrogen infusion solution without opening the infusion bag. Taiyo Co Ltd. presented reasonably priced devices to measure H2 gas in breath. Takaoka Co Ltd. demonstrated a tiny home apparatus to produce hydrogen water. Doctor's Choice Co Ltd. demonstrated powders to prepare a hydrogen bath at home using a new material that releases H2 gas. These new products will help expand our knowledge and applicability of hydrogen research.

Declarations

Acknowledgements

We would like to express our sincere thanks to all the meeting participants and staff, especially Dr. Mikako Ito at Nagoya University, who conducted the meeting.

Authors’ Affiliations

(1)
Department of Biochemistry and Cell Biology, Institute of Development and Aging Sciences, Graduate School of Medicine, Nippon Medical School
(2)
Thomas E Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh Medical Center
(3)
Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine

References

  1. Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, Katsura K, Katayama Y, Asoh S, Ohta S: Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med. 2007, 13: 688-694. 10.1038/nm1577.View ArticlePubMedGoogle Scholar
  2. Cai J, Kang Z, Liu WW, Luo X, Qiang S, Zhang JH, Ohta S, Sun X, Xu W, Tao H, Li R: Hydrogen therapy reduces apoptosis in neonatal hypoxia-ischemia rat model. Neurosci Lett. 2008, 441: 167-172. 10.1016/j.neulet.2008.05.077.View ArticlePubMedGoogle Scholar
  3. Buchholz BM, Kaczorowski DJ, Sugimoto R, Yang R, Wang Y, Billiar TR, McCurry KR, Bauer AJ, Nakao A: Hydrogen inhalation ameliorates oxidative stress in transplantation induced intestinal graft injury. Am J Transplant. 2008, 8: 2015-2024. 10.1111/j.1600-6143.2008.02359.x.View ArticlePubMedGoogle Scholar
  4. Cardinal JS, Zhan JH, Wang YN, Sugimoto R, Tsung A, McCurry KR, Billiar TR, Nakao A: Oral hydrogen water prevents chronic allograft nephropathy in rats. Kidney Int. 2010, 77: 101-109. 10.1038/ki.2009.421.View ArticlePubMedGoogle Scholar
  5. Kajiya M, Sato K, Silva MJ, Ouhara K, Do PM, Shanmugam KT, Kawai T: Hydrogen from intestinal bacteria is protective for Concanavalin A-induced hepatitis. Biochem Biophys Res Commun. 2009, 386: 316-321. 10.1016/j.bbrc.2009.06.024.View ArticlePubMedGoogle Scholar
  6. Sato Y, Kajiyama S, Amano A, Kondo Y, Sasaki T, Handa S, Takahashi R, Fukui M, Hasegawa G, Nakamura N, et al: Hydrogen-rich pure water prevents superoxide formation in brain slices of vitamin C-depleted SMP30/GNL knockout mice. Biochem Biophys Res Commun. 2008, 375: 346-350. 10.1016/j.bbrc.2008.08.020.View ArticlePubMedGoogle Scholar
  7. Matchett GA, Fathali N, Hasegawa Y, Jadhav V, Ostrowski RP, Martin RD, Dorotta IR, Sun X, Zhang JH: Hydrogen gas is ineffective in moderate and severe neonatal hypoxia-ischemia rat models. Brain Res. 2009, 1259: 90-97.View ArticlePubMedGoogle Scholar
  8. Cai JM, Kang ZM, Liu K, Liu WW, Li RP, Zhang JH, Luo X, Sun XJ: Neuroprotective effects of hydrogen saline in neonatal hypoxia-ischemia rat model. Brain Res. 2009, 1256: 129-137.View ArticlePubMedGoogle Scholar
  9. Domoki F, Olah O, Zimmermann A, Nemeth I, Toth-Szuki V, Hugyecz M, Temesvari P, Bart F: Hydrogen is Neuroprotective and Preserves Cerebrovascular Reactivity in Asphyxiated Newborn Pigs. Pediatr Res. 2010, 68: 387-392.PubMedGoogle Scholar
  10. Nagata K, Nakashima-Kamimura N, Mikami T, Ohsawa I, Ohta S: Consumption of Molecular Hydrogen Prevents the Stress-Induced Impairments in Hippocampus-Dependent Learning Tasks during Chronic Physical Restraint in Mice. Neuropsychopharmacology. 2009, 34: 501-508. 10.1038/npp.2008.95.View ArticlePubMedGoogle Scholar
  11. Li J, Wang C, Zhang JH, Cai JM, Cao YP, Sun XJ: Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer's disease by reduction of oxidative stress. Brain Res. 2010, 1328: 152-161.View ArticlePubMedGoogle Scholar
  12. Gu Y, Huang CS, Inoue T, Yamashita T, Ishida T, Kang KM, Nakao A: Drinking Hydrogen Water Ameliorated Cognitive Impairment in Senescence-Accelerated Mice. Journal of Clinical Biochemistry and Nutrition. 2010, 46: 269-276. 10.3164/jcbn.10-19.PubMed CentralView ArticlePubMedGoogle Scholar
  13. Fu Y, Ito M, Fujita Y, Ito M, Ichihara M, Masuda A, Suzuki Y, Maesawa S, Kajita Y, Hirayama M, et al: Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease. Neurosci Lett. 2009, 453: 81-85. 10.1016/j.neulet.2009.02.016.View ArticlePubMedGoogle Scholar
  14. Fujita K, Seike T, Yutsudo N, Ohno M, Yamada H, Yamaguchi H, Sakumi K, Yamakawa Y, Kido MA, Takaki A, et al: Hydrogen in drinking water reduces dopaminergic neuronal loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. PLoS One. 2009, 4: e7247-10.1371/journal.pone.0007247.PubMed CentralView ArticlePubMedGoogle Scholar
  15. Chen CH, Manaenko A, Zhan Y, Liu WW, Ostrowki RP, Tang J, Zhang JH: Hydrogen Gas Reduced Acute Hyperglycemia-Enhanced Hemorrhagic Transformation In A Focal Ischemia Rat Model. Neuroscience. 2010, 169: 402-414. 10.1016/j.neuroscience.2010.04.043.PubMed CentralView ArticlePubMedGoogle Scholar
  16. Ji XT, Liu WB, Xie KL, Liu WP, Qu Y, Chao XD, Chen T, Zhou J, Fei Z: Beneficial effects of hydrogen gas in a rat model of traumatic brain injury via reducing oxidative stress. Brain Res. 2010, 1354: 196-205.View ArticlePubMedGoogle Scholar
  17. Chen CW, Chen QB, Mao YF, Xu SM, Xia CY, Shi XY, Zhang JH, Yuan HB, Sun XJ: Hydrogen-Rich Saline Protects Against Spinal Cord Injury in Rats. Neurochem Res. 2010, 35: 1111-1118. 10.1007/s11064-010-0162-y.View ArticlePubMedGoogle Scholar
  18. Oharazawa H, Igarashi T, Yokota T, Fujii H, Suzuki H, Machide M, Takahashi H, Ohta S, Ohsawa I: Protection of the Retina by Rapid Diffusion of Hydrogen: Administration of Hydrogen-Loaded Eye Drops in Retinal Ischemia-Reperfusion Injury. Invest Ophthalmol Vis Sci. 2010, 51: 487-492. 10.1167/iovs.09-4089.View ArticlePubMedGoogle Scholar
  19. Kubota M, Shimmura S, Kubota S, Miyashita H, Kato N, Noda K, Ozawa Y, Usui T, Ishida S, Umezawa K, Kurihara T, Tsubota K: Hydrogen and N-acetyl-L-cysteine rescue oxidative stress-induced angiogenesis in a mouse corneal alkali-burn model. Invest Ophthalmol Vis Sci. 2011, 52: 427-433. 10.1167/iovs.10-6167.View ArticlePubMedGoogle Scholar
  20. Kikkawa YS, Nakagawa T, Horie RT, Ito J: Hydrogen protects auditory hair cells from free radicals. Neuroreport. 2009, 20: 689-694. 10.1097/WNR.0b013e32832a5c68.View ArticlePubMedGoogle Scholar
  21. Taura A, Kikkawa YS, Nakagawa T, Ito J: Hydrogen protects vestibular hair cells from free radicals. Acta Otolaryngol (Stockh). 2010, 130: 95-100.View ArticleGoogle Scholar
  22. Lin Y, Kashio A, Sakamoto T, Suzukawa K, Kakigi A, Yamasoba T: Hydrogen in drinking water attenuates noise-induced hearing loss in guinea pigs. Neurosci Lett. 2011, 487: 12-16. 10.1016/j.neulet.2010.09.064.View ArticlePubMedGoogle Scholar
  23. Ye J, Li Y, Hamasaki T, Nakamichi N, Komatsu T, Kashiwagi T, Teruya K, Nishikawa R, Kawahara T, Osada K, et al: Inhibitory effect of electrolyzed reduced water on tumor angiogenesis. Biological & Pharmaceutical Bulletin. 2008, 31: 19-26. 10.1248/bpb.31.19.View ArticleGoogle Scholar
  24. Zheng J, Liu K, Kang ZM, Cai JM, Liu WW, Xu WG, Li RP, Tao HY, Zhang JH, Sun XJ: Saturated hydrogen saline protects the lung against oxygen toxicity. Undersea Hyperb Med. 2010, 37: 185-192.PubMedGoogle Scholar
  25. Sun QA, Cai JM, Liu SL, Liu Y, Xu WG, Tao HY, Sun XJ: Hydrogen-Rich Saline Provides Protection Against Hyperoxic Lung Injury. J Surg Res. 2011, 165: E43-E49. 10.1016/j.jss.2010.09.024.View ArticlePubMedGoogle Scholar
  26. Kawamura T, Huang CS, Tochigi N, Lee S, Shigemura N, Billiar TR, Okumura M, Nakao A, Toyoda Y: Inhaled Hydrogen Gas Therapy for Prevention of Lung Transplant-Induced Ischemia/Reperfusion Injury in Rats. Transplantation. 2010, 90: 1344-1351. 10.1097/TP.0b013e3181fe1357.View ArticlePubMedGoogle Scholar
  27. Hayashida K, Sano M, Ohsawa I, Shinmura K, Tamaki K, Kimura K, Endo J, Katayama T, Kawamura A, Kohsaka S, et al: Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun. 2008, 373: 30-35. 10.1016/j.bbrc.2008.05.165.View ArticlePubMedGoogle Scholar
  28. Sun Q, Kang ZM, Cai JM, Liu WW, Liu Y, Zhang JH, Denoble PJ, Tao HY, Sun XJ: Hydrogen-Rich Saline Protects Myocardium Against Ischemia/Reperfusion Injury in Rats. Exp Biol Med. 2009, 234: 1212-1219. 10.3181/0812-RM-349.View ArticleGoogle Scholar
  29. Nakao A, Kaczorowski DJ, Wang YN, Cardinal JS, Buchholz BM, Sugimoto R, Tobita K, Lee S, Toyoda Y, Billiar TR, McCurry KR: Amelioration of rat cardiac cold ischemia/reperfusion injury with inhaled hydrogen or carbon monoxide, or both. J Heart Lung Transplant. 2010, 29: 544-553. 10.1016/j.healun.2009.10.011.View ArticlePubMedGoogle Scholar
  30. Qian LR, Cao F, Cui JG, Wang YC, Huang YC, Chuai YH, Zaho LQ, Jiang H, Cai JM: The Potential Cardioprotective Effects of Hydrogen in Irradiated Mice. J Radiat Res (Tokyo). 2010, 51: 741-747. 10.1269/jrr.10093.View ArticleGoogle Scholar
  31. Fukuda K, Asoh S, Ishikawa M, Yamamoto Y, Ohsawa I, Ohta S: Inhalation of hydrogen gas suppresses hepatic injury caused by ischemia/reperfusion through reducing oxidative stress. Biochem Biophys Res Commun. 2007, 361: 670-674. 10.1016/j.bbrc.2007.07.088.View ArticlePubMedGoogle Scholar
  32. Liu Q, Shen WF, Sun HY, Fan DF, Nakao A, Cai JM, Yan G, Zhou WP, Shen RX, Yang JM, Sun XJ: Hydrogen-rich saline protects against liver injury in rats with obstructive jaundice. Liver International. 2010, 30: 958-968. 10.1111/j.1478-3231.2010.02254.x.View ArticlePubMedGoogle Scholar
  33. Nakashima-Kamimura N, Mori T, Ohsawa I, Asoh S, Ohta S: Molecular hydrogen alleviates nephrotoxicity induced by an anti-cancer drug cisplatin without compromising anti-tumor activity in mice. Cancer Chemother Pharmacol. 2009Google Scholar
  34. Kitamura A, Kobayashi S, Matsushita T, Fujinawa H, Murase K: Experimental verification of protective effect of hydrogen-rich water against cisplatin-induced nephrotoxicity in rats using dynamic contrast-enhanced CT. Br J Radiol. 2010, 83: 509-514. 10.1259/bjr/25604811.PubMed CentralView ArticlePubMedGoogle Scholar
  35. Nakayama M, Kabayama S, Nakano H, Zhu WJ, Terawaki H, Nakayama K, Katoh K, Satoh T, Ito S: Biological Effects of Electrolyzed Water in Hemodialysis. Nephron Clinical Practice. 2009, 112: C9-C15. 10.1159/000210569.View ArticlePubMedGoogle Scholar
  36. Nakayama M, Nakano H, Hamada H, Itami N, Nakazawa R, Ito S: A novel bioactive haemodialysis system using dissolved dihydrogen (H-2) produced by water electrolysis: a clinical trial. Nephrology Dialysis Transplantation. 2010, 25: 3026-3033. 10.1093/ndt/gfq196.View ArticleGoogle Scholar
  37. Chen H, Sun YP, Li Y, Liu WW, Xiang HG, Fan LY, Sun Q, Xu XY, Cai JM, Ruan CP, et al: Hydrogen-rich saline ameliorates the severity of L-arginine-induced acute pancreatitis in rats. Biochem Biophys Res Commun. 2010, 393: 308-313. 10.1016/j.bbrc.2010.02.005.View ArticlePubMedGoogle Scholar
  38. Mao YF, Zheng XF, Cai JM, You XM, Deng XM, Zhang JH, Jiang L, Sun XJ: Hydrogen-rich saline reduces lung injury induced by intestinal ischemia/reperfusion in rats. Biochem Biophys Res Commun. 2009, 381: 602-605. 10.1016/j.bbrc.2009.02.105.View ArticlePubMedGoogle Scholar
  39. Zheng X, Mao Y, Cai J, Li Y, Liu W, Sun P, Zhang JH, Sun X, Yuan H: Hydrogen-rich saline protects against intestinal ischemia/reperfusion injury in rats. Free Radic Res. 2009, 43: 478-484. 10.1080/10715760902870603.View ArticlePubMedGoogle Scholar
  40. Kajiya M, Silva MJ, Sato K, Ouhara K, Kawai T: Hydrogen mediates suppression of colon inflammation induced by dextran sodium sulfate. Biochem Biophys Res Commun. 2009, 386: 11-15. 10.1016/j.bbrc.2009.05.117.View ArticlePubMedGoogle Scholar
  41. Ohsawa I, Nishimaki K, Yamagata K, Ishikawa M, Ohta S: Consumption of hydrogen water prevents atherosclerosis in apoliporotein E knockout mice. Biochem Biophys Res Commun. 2008, 377: 1195-1198. 10.1016/j.bbrc.2008.10.156.View ArticlePubMedGoogle Scholar
  42. Kajiyama S, Hasegawa G, Asano M, Hosoda H, Fukui M, Nakamura N, Kitawaki J, Imai S, Nakano K, Ohta M, et al: Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Nutrition Research. 2008, 28: 137-143. 10.1016/j.nutres.2008.01.008.View ArticlePubMedGoogle Scholar
  43. Nakao A, Toyoda Y, Sharma P, Evans M, Guthrie N: Effectiveness of Hydrogen Rich Water on Antioxidant Status of Subjects with Potential Metabolic Syndrome-An Open Label Pilot Study. Journal of Clinical Biochemistry and Nutrition. 2010, 46: 140-149. 10.3164/jcbn.09-100.PubMed CentralView ArticlePubMedGoogle Scholar
  44. Kamimura N, Nishimaki K, Ohsawa I, Ohta S: Molecular Hydrogen Improves Obesity and Diabetes by Inducing Hepatic FGF21 and Stimulating Energy Metabolism in db/db Mice. Obesity. 2011,Google Scholar
  45. Saitoh Y, Okayasu H, Xiao L, Harata Y, Miwa N: Neutral pH hydrogen-enriched electrolyzed water achieves tumor-preferential clonal growth inhibition over normal cells and tumor invasion inhibition concurrently with intracellular oxidant repression. Oncol Res. 2008, 17: 247-255. 10.3727/096504008786991620.View ArticlePubMedGoogle Scholar
  46. Itoh T, Fujita Y, Ito M, Masuda A, Ohno K, Ichihara M, Kojima T, Nozawa Y, Ito M: Molecular hydrogen suppresses FcepsilonRI-mediated signal transduction and prevents degranulation of mast cells. Biochem Biophys Res Commun. 2009, 389: 651-656. 10.1016/j.bbrc.2009.09.047.View ArticlePubMedGoogle Scholar
  47. Xie KL, Yu YH, Pei YP, Hou LC, Chen SY, Xiong LZ, Wang GL: Protective effects of hydrogen gas on murine polymicrobial sepsis via reducing oxidative stress and hmgb1 release. Shock. 2010, 34: 90-97.View ArticlePubMedGoogle Scholar
  48. Kawasaki H, Guan JJ, Tamama K: Hydrogen gas treatment prolongs replicative lifespan of bone marrow multipotential stromal cells in vitro while preserving differentiation and paracrine potentials. Biochem Biophys Res Commun. 2010, 397: 608-613. 10.1016/j.bbrc.2010.06.009.View ArticlePubMedGoogle Scholar
  49. Qian LR, Cao F, Cui JG, Huang YC, Zhou XJ, Liu SL, Cai JM: Radioprotective effect of hydrogen in cultured cells and mice. Free Radic Res. 2010, 44: 275-282. 10.3109/10715760903468758.View ArticlePubMedGoogle Scholar
  50. Qian LR, Li BL, Cao F, Huang YC, Liu SL, Cai JM, Gao F: Hydrogen-rich pbs protects cultured human cells from ionizing radiation-induced cellular damage. Nuclear Technology & Radiation Protection. 2010, 25: 23-29. 10.2298/NTRP1001023Q.View ArticleGoogle Scholar
  51. Shimouchi A, Nose K, Takaoka M, Hayashi H, Kondo T: Effect of Dietary Turmeric on Breath Hydrogen. Dig Dis Sci. 2009, 54: 1725-1729. 10.1007/s10620-008-0550-1.View ArticlePubMedGoogle Scholar
  52. Suzuki Y, Sano M, Hayashida K, Ohsawa I, Ohta S, Fukuda K: Are the effects of alpha-glucosidase inhibitors on cardiovascular events related to elevated levels of hydrogen gas in the gastrointestinal tract?. FEBS Lett. 2009, 583: 2157-2159. 10.1016/j.febslet.2009.05.052.View ArticlePubMedGoogle Scholar

Copyright

© Ohta et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.